RESUMEN
ABSTRACT: Isaac syndrome is one of the rare peripheral nerve hyperexcitability (PNH) syndromes, which manifests with gross fasciculations, muscle undulation, twitching, and cramps, with or without autonomic and sensory symptoms. The diagnosis relies on characteristic electromyogram findings and the presence of anti-leucine-rich glial inactivated 1 and anti-contactin-associated protein 2 antibodies in the serum. Here, we report the case of a 21-year-old woman, who presented with extremities and tongue myokymia whose electromyogram findings were compatible with PNH, albeit seronegative for antibodies. Neuromuscular ultrasound was performed showing high-frequency rotatory, to-and-fro, high-amplitude movement of superficial and deep muscle fascicles, more prominent in the proximal than distal muscles. Neuromuscular ultrasound may be a useful adjunct in the diagnosis of PNH.
Asunto(s)
Síndrome de Isaacs , Miocimia , Femenino , Humanos , Adulto Joven , Autoanticuerpos , Síndrome de Isaacs/diagnóstico por imagen , Calambre Muscular , Músculo Esquelético , Miocimia/diagnóstico por imagen , Nervios PeriféricosAsunto(s)
Enfermedades del Nervio Facial/etiología , Síndrome de Isaacs/etiología , Neuroma Acústico/radioterapia , Radiocirugia/efectos adversos , Anciano , Anticonvulsivantes/uso terapéutico , Carbamazepina/uso terapéutico , Enfermedades del Nervio Facial/diagnóstico por imagen , Enfermedades del Nervio Facial/tratamiento farmacológico , Femenino , Humanos , Síndrome de Isaacs/diagnóstico por imagen , Síndrome de Isaacs/tratamiento farmacológico , Imagen por Resonancia Magnética , Neuroma Acústico/diagnóstico por imagen , Resultado del TratamientoAsunto(s)
Diplopía/complicaciones , Síndrome de Isaacs/complicaciones , Anciano , Técnicas de Diagnóstico Oftalmológico , Diplopía/diagnóstico por imagen , Diplopía/patología , Femenino , Humanos , Síndrome de Isaacs/diagnóstico por imagen , Síndrome de Isaacs/patología , Imagen por Resonancia Magnética , Examen Neurológico , Tomógrafos Computarizados por Rayos XAsunto(s)
Enfermedades del Nervio Abducens/diagnóstico por imagen , Exotropía/diagnóstico por imagen , Síndrome de Isaacs/diagnóstico por imagen , Grabación de Cinta de Video , Enfermedades del Nervio Abducens/complicaciones , Adulto , Exotropía/complicaciones , Femenino , Humanos , Síndrome de Isaacs/complicacionesAsunto(s)
Síndrome de Isaacs/diagnóstico , Enfermedades del Nervio Oculomotor/diagnóstico , Anciano , Diagnóstico Diferencial , Femenino , Humanos , Síndrome de Isaacs/diagnóstico por imagen , Síndrome de Isaacs/psicología , Imagen por Resonancia Magnética , Enfermedades del Nervio Oculomotor/diagnóstico por imagenRESUMEN
IMPORTANCE: Autoantibodies against contactin-associated protein-like 2 (CASPR2) are observed in several neurological syndromes, including neuromyotonia (NMT), Morvan syndrome (MoS), and limbic encephalitis. OBJECTIVE: To characterize the clinical and biological presentations of patients with anti-CASPR2 antibodies in the cerebrospinal fluid (CSF). DESIGN, SETTING, AND PARTICIPANTS: We conducted a retrospective cohort analysis of 18 patients who had anti-CASPR2 antibodies in their CSF between March 2009 and November 2015 at the Centre National de Référence pour les Syndromes Neurologiques Paranéoplasiques in Lyon, France. Additionally, we analyzed 15 patients who were diagnosed as having NMT or MoS as a comparative group. MAIN OUTCOMES AND MEASURES: Clinical presentations, anti-CASPR2 antibodies specificities, brain magnetic resonance imaging, and CSF analyses, cancer prevalence, and evolution. RESULTS: In this cohort of 18 patients with anti-CASPR2 antibodies in their CSF, 17 (94.4%) were male and had a median (range) age of 64.5 (53-75) years; in the second group, 9 of 15 patients (60.0%) with NMT or MoS were male and had a median (range) age of 51 years (1 month to 75 years). Only 3 patients (16.7%) in this cohort had a previous or concomitant history of cancer (prostate, hematological, or thyroid), whereas 9 patients (60.0%) in the second group had a malignant thymoma. Symptoms of limbic encephalitis were observed in all patients, including temporal lobe seizures in 16 patients (88.9%) and memory disorders in 17 patients (94.4%) from the cohort. Extralimbic signs were also evident in 12 of 18 patients (66.7%), including cerebellar ataxia in 6 patients (33.3%). Only 2 patients (11.1%) from the cohort were diagnosed as having NMT. Brain magnetic resonance imaging displayed T2-weighted temporolimbic abnormalities in 14 of 15 patients (93.3%) in the second group. Cerebrospinal fluid analysis was abnormal in 9 of 12 patients (75.0%). For 16 of 18 patients (88.9%), follow-up was performed for at least a 6-month period (median [range], 34 [11-114] months). Of these, 15 (93.8%) improved and 6 (37.5%) relapsed. In all patients in this cohort, IgG4 autoantibodies were detected in the CSF. Anti-CASPR2 antibodies in the CSF targeted the laminin G1 and discoidin domains of CASPR2 in all patients. Importantly, anti-CASPR2 antibodies were detected in the serum but not in the CSF of all patients with NMT or MoS. CONCLUSIONS AND RELEVANCE: In this cohort study, anti-CASPR2 antibodies in the CSF are associated with a subtype of autoimmune encephalitis with prominent limbic involvement and seizures that is rarely associated with cancer. Conversely, patients with NMT and MoS have anti-CASPR2 antibodies only in the serum but not in the CSF and frequently present with a malignant thymoma. The anti-CASPR2 antibodies found in these patients targeted the discoidin and laminin G1 domains of CASPR2 and always included IgG4 autoantibodies.
Asunto(s)
Autoanticuerpos/líquido cefalorraquídeo , Encefalitis Límbica/líquido cefalorraquídeo , Proteínas de la Membrana/inmunología , Proteínas del Tejido Nervioso/inmunología , Convulsiones/líquido cefalorraquídeo , Anciano , Femenino , Estudios de Seguimiento , Francia , Humanos , Síndrome de Isaacs/líquido cefalorraquídeo , Síndrome de Isaacs/diagnóstico por imagen , Síndrome de Isaacs/tratamiento farmacológico , Encefalitis Límbica/complicaciones , Encefalitis Límbica/diagnóstico por imagen , Encefalitis Límbica/tratamiento farmacológico , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Miocimia/líquido cefalorraquídeo , Miocimia/diagnóstico por imagen , Miocimia/tratamiento farmacológico , Estudios Retrospectivos , Convulsiones/complicaciones , Convulsiones/diagnóstico por imagen , Convulsiones/tratamiento farmacológico , Esteroides/uso terapéuticoAsunto(s)
Diplopía/diagnóstico , Síndrome de Isaacs/diagnóstico , Neuroimagen/métodos , Músculos Oculomotores/fisiopatología , Enfermedades del Nervio Oculomotor/diagnóstico , Diplopía/etiología , Humanos , Síndrome de Isaacs/complicaciones , Síndrome de Isaacs/diagnóstico por imagen , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Neurología/educación , Enfermedades del Nervio Oculomotor/complicaciones , Enfermedades del Nervio Oculomotor/diagnóstico por imagenRESUMEN
BACKGROUND: Neuromyotonia (NM), Isaacs-Zschoke-Mertens syndrome or continuous muscle fiber activity (CMFA), is a rare condition associated with VGKC-antibodies. Clinically, fasciculations, myokymias, muscle stiffness and a myotonic appearance of movements after contraction are typical findings. In addition, CNS-symptoms vary from moderate fatigue, poor concentration and autonomic symptoms to severe encephalopathy in Morvan's syndrome. In electromyography, spontaneous irregular discharges can be found frequently with typical di-, tri- or multiplet single motor unit discharges. In up to 60â%, serum antibodies against VGKC-complexes can be detected. METHODS: Patients with neuromyotonia were evaluated for clinical symptoms, response to treatment and outcome over a five-year period of follow-up.âFor evaluation, we used video recording of clinical symptoms, electroneurography, electromyography and myosonography as well as immunological tests (VGKC-complex antibody including CASPR2 and IGL1). Furthermore, cerebral fluid and screening for neoplasias were done. Patients with evidence for neuropathy, myopathy or motor neuron disease, even if diagnosed in the follow-up, were excluded. RESULTS: In 3 of 5 patients, neuromyotonia was diagnosed by electromyography and positive VGKC antibodies. In two patients, diagnosis was based on typical clinical symptoms and electromyographical changes. Anticonvulsants (carbamazepine) for symptomatic treatment were moderately effective in four patients; treatment with i.âv. immunoglobulins was highly successful in one patient with high positive VGKC-complex antibody titers. In one patient with low-titer VGKC antibodies, neither anticonvulsants nor i.âv. immunoglobulins nor prednisone was a successful treatment. CONCLUSIONS: Neuromyotonia is a rare, treatable condition. However, due to the high variability of symptoms, response to therapy and outcome, neuromyotonia treatment needs to be highly individualized.